Cooley Godward
$647 MILLION ACQUISITION
IS ELEMENTARY FOR WATSON
Watson Pharmaceuticals Inc., based in Corona, is in the process of acquiring Schein Pharmaceutical Inc., headquartered in Florham, N.J. The $647 million cash and stock transaction is expected to close in July. The companies had previously been rivals in the pharmaceutical market.
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy
here.